PubMed Health⌕ Search

Biomedical subjects

Hui-ling Yang

Publications and source records attributed to Hui-ling Yang.

3 recordsLinked to original sources

[A reverse transcriptase-polymerase chain reaction method improving the specific amplification of caveolin-1 gene sequences].

OBJECTIVE: To construct a reverse transcriptase-polymerase chain reaction (RT-PCR)approach that can improve the specificity of primers while dropping down the nonspecific amplification. METHODS: In the recent study we reported a new RT-PCR assay which improved markedly the specificity. However its efficiency of regressing nonspecific amplification remains to be accurately checked and further documented. In primer design, we looked over again some sequences that showed differences at 5' or 3' ends between human CAV1 and mouse Cav1 genes. cDNAs and the diluted plasmids which harbored the sequence of human CAV1 or mouse Cav1 gene were chosen as the templates. The ordinary PCR compared with one, of which primers modified by phosphorothioate and combined with proofreading polymerase, for their efficiencies of nonspecific amplification inhibited. RESULTS: Taq DNA polymerase without proofreading activity could efficiently catalyze the extension of primers with a single or multiple mismatched base pairs at the 3' terminus, but the kind of primer extension can be effectively blocked by phosphorothioate modified primers combined with proofreading polymerase. Compared with ordinary PCR reaction, this new PCR method can effectively regress the primer mismatched amplification of 50 ng DNA almost equaling to 2 x 10(4) unmatched template copies in a final volume of 50 microL. CONCLUSION: Compared with the first generation of polymerases with or without proofreading activities mediating RT-PCR reaction, the introduction of nuclease-resistant 3' modified primers (3' phosphorothioate primer extension) can offer more simplicity, accuracy, and also decrease cost.

Animals↗

[Cloning, sequencing and expressing of microneme protein 1 partial gene in toxoplasma gondii ZS2 isolate].

OBJECTIVE: To construct a recombinant prokaryotic expression vector (plasmid) containing microneme protein 1 (MIC1) partial gene in toxoplasma gondii (T. gondii) ZS2 isolate. The gene was expressed in varied Escherichia coli (E. coli) after sequencing. METHODS: The gene fragment coding MIC 1 from the genomic DNA of T. gondii ZS2 isolate was amplified by polymerase chain reaction (PCR). The gene was inserted to a prokaryotic expression vector pWR450-1 by digesting with restriction enzymes and linking reaction. The positive clone was screened on LB plates containing ampicillin and identified by restrictive enzyme digestion, PCR amplification and sequence analysis. The recombinant plasmid was transferred into E. coli TG1, JM109 (DE3) and DH5 alpha, and was expressed under the induction of IPTG. The expression products were identified by SDS-PAGE. The MIC1 gene structure was analyzed and compared in homology with the gene sequence of RH isolate using computer software. RESULTS: The recombinant plasmid pWR450-1/MIC1, after cloning from acquired 471 bp MIC1 gene fragment and amplified from the genome gene ZS2, was complete homologous to the sequence of RH isolate, reflecting its highly conservative. The gene could be expressed as fusion protein with 70,000 in varied E. coli. CONCLUSION: Recombinant plasmid pWR450-MIC1 was successfully constructed and could be expressed in different strains of E. coli, laying a foundation for research on its structure and function.

Animals↗

[Retrospective analysis of the studies on sleep apnea-hypopnea syndrome in the past twenty years in our country].

OBJECTIVE: To summarize and evaluate the studies on sleep apnea-hypopnea syndrome (SAHA) in our country. METHOD: Articles on the study of SAHS published in major journals of our country from January, 1982 to June, 2002 were evaluated retrospectively. RESULTS: 262 articles were recruited. More papers covering more aspects of this disorder were getting published in the past 20 years. However, basic studies, multidisciplinary studies, more effective therapies and large size, multicenter, and prospective trials were lacking. The study of SAHS in different provinces did not reach the same level. CONCLUSION: Large sampled, multicenter and multidisciplinary prospective trials are needed to study more effective and acceptable therapies as well as the basic mechanism of SAHS.

Biomedical Research↗